학술논문

Maintenance of quality of life in adults with type 1 Gaucher disease previously stabilized on enzyme therapy who were switched to oral eliglustat: 4 year results of the ENCORE trial.
Document Type
Article
Source
Molecular Genetics & Metabolism. Jan2017, Vol. 120 Issue 1/2, pS37-S38. 1p.
Subject
*GAUCHER'S disease
*GAUCHER'S disease treatment
*THERAPEUTIC use of enzymes
*QUALITY of life
*STABILIZING agents
*PATIENTS
*THERAPEUTICS
Language
ISSN
1096-7192